BRIEF-Fosun Pharmaceutical Says Unit Signs Licensing Agreement With Pfizer

Reuters
Dec 09, 2025
BRIEF-Fosun Pharmaceutical Says Unit Signs Licensing Agreement With Pfizer

Dec 9 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd 600196.SS:

  • SAYS UNIT SIGNS GLP-1R LICENSING AGREEMENT WITH PFIZER

  • SAYS UNIT TO RECEIVE UPFRONT PAYMENT OF $150 MILLION

Source text

Further company coverage: 600196.SS

(Reporting by Beijing Newsroom)

((Ethan.Wang@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10